SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

BioScrip Q3 EPS $(0.07) Misses $(0.02) Estimate, Sales $615.88M Beat $517.55M Estimate

BioScrip (NASDAQ:BIOS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.02) by 250 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same

Benzinga · -

BioScrip (NASDAQ:BIOS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.02) by 250 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $615.88 million which beat the analyst consensus estimate of $517.55 million by 19.00 percent. This is a 240.34 percent increase over sales of $180.962 million the same period last year.